The latest on artificial intelligence transforming medicine

AI Breast Risk Tools Move Into the Guidelines as Screening Becomes More Personalized

Multiple reports point to a turning point in breast cancer screening: AI-based risk assessment is being folded into major guideline updates. That could help clinicians personalize screening earlier, rather than waiting for symptoms or age thresholds to drive care. The opportunity is real, but so are the implementation challenges, including bias, calibration, and how to explain algorithmic risk to patients.